Litcius/Paper detail

PD-L1 expression in gastric cancer: interchangeability of 22C3 and 28-8 pharmDx assays for responses to immunotherapy

Soomin Ahn, Kyoung‐Mee Kim

2021Modern Pathology94 citationsDOIOpen Access PDF

Topics & Concepts

PembrolizumabMedicineConcordanceInternal medicineNivolumabOncologyCancerImmunotherapyCancer Immunotherapy and BiomarkersGastric Cancer Management and OutcomesColorectal Cancer Treatments and Studies
PD-L1 expression in gastric cancer: interchangeability of 22C3 and 28-8 pharmDx assays for responses to immunotherapy | Litcius